Howard Hughes Medical Institute’s Blackstone BX Stock Holding History

Howard Hughes Medical Institute’s Portfolio BX Stock Details BX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-159	Closed	-$24.5K	–	96
2025 Q4	$24.5K	Buy	159 +1	+0.6%	+$152	0.01%	97
2025 Q3	$27K	Hold	158	–	–	0.02%	88
2025 Q2	$23.6K	Buy	+158	New	+$21.7K	0.01%	94

Other funds holding BX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Howard Hughes Medical Institute's BX Position: Q1 2026 in Review

Howard Hughes Medical Institute sold out of Blackstone (BX) in Q1 2026, closing a stake of 159 shares — an estimated $24.5K sold.

Howard Hughes Medical Institute first reported a position in BX in Q2 2025 and held it in 3 quarters. The position peaked at $27K in Q3 2025. 2,126 funds tracked by Wall St. Rank hold BX as of Q1 2026.

Howard Hughes Medical Institute reported no remaining Blackstone position as of Q1 2026 after selling out during the quarter.
Howard Hughes Medical Institute sold 159 Blackstone shares in Q1 2026, an estimated $24.5K.
Howard Hughes Medical Institute first reported a position in Blackstone in Q2 2025 and held it in 3 quarters.
Howard Hughes Medical Institute's Blackstone position peaked at $27K in Q3 2025.
2,126 funds tracked by Wall St. Rank held Blackstone as of Q1 2026.

Based on Howard Hughes Medical Institute's 13F filing for Q1 2026, filed 15 May 2026.